Concepedia

M. Koczywas

MK

10

Publications

335

Citations

10

H-Index

2006

Active since

Affiliations

City Of Hope National Medical Center(Current)

University of California, Davis

University of Southern California

City of Hope

National Cancer Institute

M. Koczywas is an author at City Of Hope National Medical Center specializing in cancer therapeutics, oncology, and medicine.

Top concepts

Publications per year

2006–2020

10

Publications

10

Phase II Study of the AKT Inhibitor MK-2206 plus Erlotinib in Patients with Advanced Non–Small Cell Lung Cancer Who Previously Progressed on Erlotinib

Primo N. Lara, Jeff Longmate, Philip C. Mack et al. · Clinical Cancer Research · 2015 · 83 citations

An open-label phase II study of the Hsp90 inhibitor ganetespib (STA-9090) as monotherapy in patients with advanced non-small cell lung cancer (NSCLC).

Kwok‐Kin Wong, M. Koczywas, J. W. Goldman et al. · Journal of Clinical Oncology · 2011 · 62 citations

, , +14

Phase I Trial of Intraperitoneal Gemcitabine in the Treatment of Advanced Malignancies Primarily Confined to the Peritoneal Cavity

Robert J. Morgan, Timothy W. Synold, Bixin Xi et al. · Clinical Cancer Research · 2007 · 45 citations

Bortezomib Plus Docetaxel in Advanced Non-small Cell Lung Cancer and Other Solid Tumors: A Phase I California Cancer Consortium Trial

Primo N. Lara, M. Koczywas, David I. Quinn et al. · Journal of Thoracic Oncology · 2006 · 30 citations · Full text

, , +8

Cediranib (AZD2171) for the treatment of recurrent small cell lung cancer (SCLC): A California Consortium phase II study (NCI # 7097)

Suresh S. Ramalingam, Philip C. Mack, Everett E. Vokes et al. · Journal of Clinical Oncology · 2008 · 26 citations

, , +17

Rows per page

1–5 of 10